Apollo Global Management completed the acquisition of Covis Pharma, a global specialty pharmaceutical company, from Cerberus Capital Management and Princeton BCP. Financial terms were not disclosed. "We are excited to work closely with Covis Pharma’s proven leadership team as they continue to develop treatments that improve patients’ lives. We see significant opportunities ahead as we pursue our shared vision of providing innovative pharmaceutical products to an even broader market. We believe that Covis Pharma is extremely well positioned to grow as a pharmaceutical platform given our collective expertise and Apollo’s deep financial resources," Samuel Feinstein, Apollo Partner.